Suggestions
Daniel Hollyman
Assistant Director, Performance, Cell, Apheresis and Gene Therapies at NHS Blood and Transplant
Daniel Hollyman is a senior healthcare professional currently serving as the Assistant Director of Performance, Cell, Apheresis and Gene Therapies at NHS Blood and Transplant.2 His role involves overseeing critical aspects of stem cell transplantation and cellular therapies within the UK's national health service.
Professional Background
Hollyman has held several prominent positions within NHS Blood and Transplant, showcasing his expertise in the field of stem cell and immunotherapy:
- Current Role: Assistant Director, Performance, Cell, Apheresis and Gene Therapies2
- Previous Position: Interim Assistant Director of Stem Cells & Immunotherapies
His career trajectory demonstrates a strong focus on advancing stem cell transplantation and cellular therapies in the UK healthcare system.
Contributions to the Field
Daniel Hollyman has been involved in shaping the future of stem cell transplantation and cellular therapies in the UK:
- He contributed to the development of "A 10 Year Vision for Stem Cell Transplantation and Cellular Therapies," a strategic document outlining plans to improve patient outcomes and strengthen the UK's position in life sciences.1
- Hollyman has worked on initiatives aimed at increasing the availability of stem cell donors, particularly focusing on recruiting young male donors and improving diversity in the donor pool.1
Expertise and Impact
Hollyman's work encompasses various critical areas:
- Stem Cell Donor Supply Chain: Involved in efforts to enhance sustainability and resilience of the stem cell donor supply.1
- Research and Innovation: Contributes to expanding the supply of high-quality donor materials for academic and commercial partnerships, fostering innovation in Advanced Therapy Medicinal Products (ATMPs).1
- Patient Outcomes: Works towards securing improvements in access, experience, and outcomes for patients requiring stem cell transplantation and cellular therapies.1
Daniel Hollyman's role at NHS Blood and Transplant positions him as a key figure in the advancement of stem cell transplantation and cellular therapies in the UK, contributing to both patient care and the broader life sciences ecosystem.